UROLOGIX TARGIS MICROWAVE BPH THERAPY DEVICE TO LIST AT $150,000, FIRM SAYS; FDA APPROVAL CLEARS WAY FOR LAUNCH OF COMPETITION TO EDAP'S PROSTATRON
This article was originally published in The Gray Sheet
Executive Summary
Urologix is heating up competition in the benign prostatic hyperplasia microwave therapy market with the U.S. launch of its Targis system, which is slated for the fourth quarter of 1997. Urologix is the second company, after Edap Technomed, to gain approval for a microwave-based BPH therapy system.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.